Issue of Shares

Summary by AI BETAClose X

Alkemy Capital Investments Plc announced the issuance of 30,838 ordinary shares at £2.90 each to Wave International and 18,478 ordinary shares at the same price to Green Wave Procurement, aligning with the Tees Valley Lithium project development. Additionally, a loan facility provider converted £167,379 in principal and £55,084 in interest into 109,139 ordinary shares at £2.04 per share. These issuances will result in a total of 158,455 new ordinary shares being admitted to trading on the London Stock Exchange on June 18, 2026, bringing the Company's enlarged share capital to 11,135,080 ordinary shares.

Disclaimer*

Alkemy Capital Investments PLC
15 June 2026
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR") AS IN FORCE IN THE UNITED KINGDOM PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

15 June 2026

 

Alkemy Capital Investments Plc

 

Issue of Shares

 

Alkemy Capital Investments plc ("Alkemy" or the "Company") (LSE: ALK) (JV2:FRA) announces that it has agreed to issue 30,838 ordinary shares to Wave International and 18,478 ordinary shares to Green Wave Procurement at £2.90 per share, being the closing price on 12 June 2026, reflecting the agreed commercial framework between the parties and to provide alignment with the continued development of the Tees Valley Lithium project.

 

The Company has also received a loan conversion notice from the debt facility provider, as set out in the RNS dated 31 July 2025, pursuant to which £167,379 of principal and £55,084 of interest is being converted at £2.04, resulting in the issue of 109,139 ordinary shares.

 

Admission

Application will be made for 158,455 new ordinary shares to be admitted to trading on the Equity Shares (transition) category of the Official List and the Main Market of the London Stock Exchange at 8.00 a.m. on 18 June 2026 ("Admission").

Total Voting Rights

The Company hereby notifies the market, in accordance with the FCA's Disclosure Guidance and Transparency Rules, that on Admission, the Company's enlarged share capital will consist of 11,135,080 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Further information

 

For further information, please visit Alkemy's website: www.alkemycapital.co.uk or TVL's website www.teesvalleylithium.co.uk).

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

Zeus Capital

Tel: 0203 829 5000

 

ABOUT US

 

Alkemy Capital Investments plc: Alkemy is focused on the development of critical mineral infrastructure to support the global energy transition. Through its wholly owned subsidiary, TVL, Alkemy is leading the way in establishing Europe's first independent lithium hydroxide refinery.

 

Tees Valley Lithium Limited: TVL is dedicated to providing battery-grade lithium chemicals to meet the growing demand of the electric vehicle supply chain in Europe. Strategically located at in Teesside, TVL is committed to sustainable, efficient, and world-class operations.

 

 

Forward Looking Statements

 

This news release contains forward‐looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward‐looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward‐looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward‐looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings